Similar articles

• Drug safety special: chasing shadows.

  Frantz S. Frantz S. Nature. 2005 Mar 31;434(7033):557-8. doi: 10.1038/434557a. Nature. 2005. PMID: 15800592 No abstract available.
• Drug safety on trial.

  [No authors listed] [No authors listed] Nature. 2005 Mar 31;434(7033):545. doi: 10.1038/434545a. Nature. 2005. PMID: 15800579 No abstract available.
• Learning the value of drugs--is rofecoxib a regulatory success story?

  Eisenberg RS. Eisenberg RS. N Engl J Med. 2005 Mar 31;352(13):1285-7. doi: 10.1056/NEJMp048358. N Engl J Med. 2005. PMID: 15800222 No abstract available.
• COX-2 inhibitors and the heart: putting risk in perspective.

  Bobadilla RV, Barnett EM, Randels CL. Bobadilla RV, et al. Adv Nurse Pract. 2005 Nov;13(11):48-50. Adv Nurse Pract. 2005. PMID: 16295003 Review. No abstract available.
• [FDA's new drug approval system].

  Ishii A. Ishii A. Gan To Kagaku Ryoho. 1995 Aug;22(9):1146-51. Gan To Kagaku Ryoho. 1995. PMID: 7661565 Review. Japanese. No abstract available.